Status:
UNKNOWN
Pre-treatment With Methylene Blue Prevent Peri-operative Reduced Systemic Vascular Resistance
Lead Sponsor:
Southwest Hospital, China
Conditions:
Obstructive Jaundice
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
To explore the effects of pre-treatment with methylene blue on reduced perioperative vascular resistance in patients with obstructive jaundice.
Detailed Description
Hemodynamic characteristics of patients with obstructive jaundice are high cardiac output, low peripheral vascular resistance. The molecular basis for this feature is the increased production of NO. M...
Eligibility Criteria
Inclusion
- Aged between 18-60 years;
- American Society of Anesthesiologists（ASA） grade I\~III;
- TBIL\>ULN and TBA\>ULN; The patients with obstructive jaundice.
Exclusion
- Organs dysfunction(heart,lungs and etc);
- Mental disorders;
- in other clinical trial.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2018
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03406676
Start Date
August 1 2017
End Date
October 30 2018
Last Update
January 23 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Hospital
Chongqing, Chongqing Municipality, China, 400038
2
Southwest Hospital
Chongqing, Chongqing Municipality, China, 400038